Publications - Allan S. Jaffe, M.D.

Back to research profile

1. Killu AM, Liang JJ, Jaffe AS. Erdheim-Chester disease with cardiac involvement successfully treated with anakinra. Int J Cardiol. 2013 May 06. [Epub ahead of print]
   View PubMed
2. Miller WL, Grill DE, Struck J, Jaffe AS. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure. Am J Cardiol. 2013 Mar 15; 111(6):880-5. Epub 2012 Dec 28.
   View PubMed
3. Keddis MT, El-Zoghby ZM, El Ters M, Rodrigo E, Pellikka PA, Jaffe AS, Cosio FG. Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survival. Am J Transplant. 2013 Feb; 13(2):406-14. Epub 2012 Nov 08.
   View PubMed
4. Nordenskjold AM, Ahlstrom H, Eggers KM, Frobert O, Jaffe AS, Venge P, Lindahl B. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem. 2013 Feb; 59(2):401-9. Epub 2012 Nov 09.
   View PubMed
5. Jaffe AS. Third universal definition of myocardial infarction. Clin Biochem. 2013 Jan; 46(1-2):1-4. Epub 2012 Nov 02.
   View PubMed
6. Korley FK, Jaffe AS. Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol. 2013; 61(17):1753-8.
7. Dunlay SM, Jaffe AS. Are biomarkers the answer to the heart failure readmissions problem? Clin Chem. 2013; 59(5):737-9.
8. Olaf S, Debora B, Ricarda B, Gunnar B, Jochen K, Schimke I, Halle M, Jaffe A. Exercise tolerance in asymptomatic patients with moderate-severe valvular heart disease and preserved ejection fraction. Arch Med Sci. 2012 Dec 20; 8(6):1018-26. Epub 2012 Dec 19.
   View PubMed
9. Sheldon SH, Crandall MA, Jaffe AS. Myocarditis with ST elevation and elevated cardiac enzymes misdiagnosed as an ST-elevation myocardial infarction. J Emerg Med. 2012 Dec; 43(6):996-9. Epub 2010 Dec 16.
   View PubMed
10. Kaleta EJ, Jaffe AS, Baumann NA, Block DR. A case of floating gel. Clin Chem. 2012 Nov; 58(11):1604-5.
    View PubMed
11. Apple FS, Jaffe AS. Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. Clin Chem. 2012 Nov; 58(11):1599-600. Epub 2012 Sep 11.
    View PubMed
12. Than M, Herbert M, Flaws D, Cullen L, Hess E, Hollander JE, Diercks D, Ardagh MW, Kline JA, Munro Z, Jaffe A. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?: A clinical survey. Int J Cardiol. 2012 Oct 18. [Epub ahead of print]
    View PubMed
13. Sheldon SH, Saenger AK, Jaffe AS. Incidence and significance of elevated lactate in the identification of critically ill patients. Clin Chem Lab Med. 2012 Oct 1; 50(10):1819-23.
    View PubMed
14. Jaffe AS. Peri-operative myocardial infarction and high sensitive cardiac troponin: A start but by no means a finish. Heart. 2012 Oct; 98(19):1402-3.
    View PubMed
15. Whang W, Burg MM, Carney RM, Freedland KE, Bigger JT, Catellier D, Czajkowski S, Frasure-Smith N, Haas DC, Jaffe AS, Lesperance F, Medina V, Duer-Hefele J, Osorio GA, Parsons F, Shapiro PA, Sheps DS, Vaccarino V, Davidson KW. Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial. Contemp Clin Trials. 2012 Sep; 33(5):1003-10. Epub 2012 May 25.
    View PubMed
16. Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M, Hasin Y, Biasucci LM, Giannitsis E, Lindahl B, Koenig W, Tubaro M, Collinson P, Katus H, Galvani M, Venge P, Alpert JS, Hamm C, Jaffe AS, Study Group on Biomarkers in Cardiology of the ESC Workin Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J. 2012 Aug; 33(16):2001-6. Epub 2011 Feb 2.
    View PubMed
17. Dunlay SM, Weston SA, Killian JM, Bell MR, Jaffe AS, Roger VL. Thirty-day rehospitalizations after acute myocardial infarction: a cohort study. Ann Intern Med. 2012 Jul 3; 157(1):11-8.
    View PubMed
18. Ayub B, Martinez MW, Jaffe AS, Couri DM. Giant saphenous vein graft pseudoaneurysm: treatment with a vascular occlusion device. Interact Cardiovasc Thorac Surg. 2012 Jul; 15(1):164-5. Epub 2012 Mar 28.
    View PubMed
19. Koch CD, Wockenfus AM, Saenger AK, Jaffe AS, Karon BS. BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer. Clin Biochem. 2012 Jul; 45(10-11):842-4. Epub 2012 Apr 26.
    View PubMed
20. Deo S, Greason KL, Gulati R, Jaffe AS, Holmes DR. Balloon aortic valvuloplasty under temporary mechanical circulatory support as a bridge to aortic valve replacement in a patient with hemodynamic failure secondary to critical aortic valve stenosis. Heart Surg Forum. 2012 Jun; 15(3):E177-9.
    View PubMed
21. Jaffe AS. Troponin--past, present, and future. Curr Probl Cardiol. 2012 Jun; 37(6):209-28.
    View PubMed
22. Miller WL, Grill DE, Jaffe AS. Comparison of novel pro-BNP(1-108) and standard BNP assays in heart failure patients. Clin Chim Acta. 2012 May 18; 413(9-10):920-6. Epub 2012 Feb 16.
    View PubMed
23. Jaffe AS, Apple FS, Lindahl B, Mueller C, Katus HA. Why all the struggle about CK-MB and PCI? Eur Heart J. 2012 May; 33(9):1046-8. Epub 2012 Jan 11.
    View PubMed
24. Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, Avidan A, Beeri R, Weissman C, Jaffe AS, Sprung CL. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J. 2012 Apr; 33(7):895-903. Epub 2011 Sep 11.
    View PubMed
25. Alpert JS, Jaffe AS. Interpreting biomarkers during percutaneous coronary intervention: the need to reevaluate our approach. Arch Intern Med. 2012 Mar 26; 172(6):508-9. Epub 2012 Feb 27.
    View PubMed
26. Gerber Y, Jaffe AS, Weston SA, Jiang R, Roger VL. Prognostic value of cardiac troponin T after myocardial infarction: a contemporary community experience. Mayo Clin Proc. 2012 Mar; 87(3):247-54.
    View PubMed
27. Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J. 2012 Mar; 33(5):579-86. Epub 2012 Jan 19.
    View PubMed
28. Miller WL, Hartman KA, Grill DE, Struck J, Bergmann A, Jaffe AS. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure. Heart. 2012 Mar; 98(5):389-94. Epub 2011 Dec 22.
    View PubMed
29. Hess EP, Brison RJ, Perry JJ, Calder LA, Thiruganasambandamoorthy V, Agarwal D, Sadosty AT, Silvilotti ML, Jaffe AS, Montori VM, Wells GA, Stiell IG. Development of a clinical prediction rule for 30-day cardiac events in emergency department patients with chest pain and possible acute coronary syndrome. Ann Emerg Med. 2012 Feb; 59(2):115-25.e1. Epub 2011 Sep 01.
    View PubMed
30. Schmickl CN, Shahjehan K, Li G, Dhokarh R, Kashyap R, Janish C, Alsara A, Jaffe AS, Hubmayr RD, Gajic O. Decision support tool for early differential diagnosis of acute lung injury and cardiogenic pulmonary edema in medical critically ill patients. Chest. 2012 Jan; 141(1):43-50. Epub 2011 Oct 26.
    View PubMed
31. Jaffe AS, Wu AH. Troponin release--reversible or irreversible injury? Should we care? Clin Chem. 2012 Jan; 58(1):148-50. Epub 2011 Oct 28.
    View PubMed
32. Katus HA, Giannitsis E, Jaffe AS. Interpreting changes in troponin--clinical judgment is essential. Clin Chem. 2012 Jan; 58(1):39-43.
    View PubMed
33. Thygesen K Mair J Giannitsis E Mueller C Lindahl B Blankenberg S Huber K Plebani M Biasucci LM Tubaro M Collinson P Venge P Hasin Y Galvani M Koenig W Hamm C Alpert JS Katus H Jaffe AS, The Study Group on Biomarkers in Cardiology of the ESC Working Group How to use high-sensitivity cardiac troponins in acute cardiac care. EHJ. 2012 Epub 2012 Jun 21.
34. Jaffe AS, Apple FS. The third universal definition of myocardial infarction - Moving forward. Clin Chem. 2012; 58(12):1727-8.
35. Koerbin G, Potter JM, Abhayaratna WP, Telford RD, Badrick T, Apple FS, Jaffe AS, Hickman PE. Longitudinal studies of cardiac troponin I in a large cohort of healthy children. Clin Chem. 2012; 58(12):1665-72.
36. Eggers KM, Jaffe AS, Svennblad B, Lindahl B. A novel approach to cardiac troponins to improve the diagnostic work-up in chest pain patients. Critical Pathways in Cardiology. 2012; 11(4):199-205.
37. Pervaiz MA, Gau G, Jaffe AS, Saenger AK, Baudhuin L, Ellison J. A Non-classical Presentation of Tangier Disease with Three ABCA1 Mutations. JIMD Rep. 2012; 4:109-11. Epub 2011 Sep 28.
    View PubMed
38. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011 Oct 18; 58(17):1819-24. Epub 2011 Sep 29.
    View PubMed
39. Oliver LK, Voskoboev N, Heser D, McConnell JP, Hodel-Hanson S, Callanan H, Jaffe AS. Assessment of clinical performance without adequate analytical validation: A prescription for confusion. Clin Biochem. 2011 Oct; 44(14-15):1247-52. Epub 2011 Jul 20.
    View PubMed
40. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, Wibberley C, Nuttall M, Mackway-Jones K. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol. 2011 Sep 20; 58(13):1332-9.
    View PubMed
41. Jaffe AS. The 10 commandments of troponin, with special reference to high sensitivity assays. Heart. 2011 Jun; 97(11):940-6.
    View PubMed
42. Schulz O, Reinicke M, Kramer J, Berghofer G, Bensch R, Schimke I, Jaffe A. Pregnancy-associated plasma protein A values in patients with stable cardiovascular disease: use of a new monoclonal antibody-based assay. Clin Chim Acta. 2011 May 12; 412(11-12):880-6. Epub 2011 Jan 14.
    View PubMed
43. Arruda-Olson AM, Roger VL, Jaffe AS, Hodge DO, Gibbons RJ, Miller TD. Troponin T levels and infarct size by SPECT myocardial perfusion imaging. JACC Cardiovasc Imaging. 2011 May; 4(5):523-33.
    View PubMed
44. Miller WL, Phelps MA, Wood CM, Schellenberger U, Van Le A, Perichon R, Jaffe AS. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure. Circ Heart Fail. 2011 May; 4(3):355-60. Epub 2011 Feb 03.
    View PubMed
45. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, Giannitsis E, Gustafson S, Handy B, Katus H, Melanson SE, Panteghini M, Venge P, Zorn M, Jarolim P, Bruton D, Jarausch J, Jaffe AS. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011 Apr 11; 412(9-10):748-54. Epub 2011 Jan 08.
    View PubMed
46. Martinez MW, Rasmussen KG, Mueller PS, Jaffe AS. Troponin elevations after electroconvulsive therapy: the need for caution. Am J Med. 2011 Mar; 124(3):229-34.
    View PubMed
47. Hallen J, Jensen JK, Buser P, Jaffe AS, Atar D. Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction. Acute Card Care. 2011 Mar; 13(1):48-51. Epub 2011 Jan 18.
    View PubMed
48. Eggers KM, Jaffe AS, Venge P, Lindahl B. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction. Clin Chim Acta. 2011 Jan 14; 412(1-2):91-7. Epub 2010 Sep 22.
    View PubMed
49. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, Lindahl B, Giannitsis E, Hasin Y, Galvani M, Tubaro M, Alpert JS, Biasucci LM, Koenig W, Mueller C, Huber K, Hamm C, Jaffe AS. Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. EHJ (in press). 2011; EHJ 2011.
50. Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, Avidan A, Beeri R, Wesissman C, Jaffe AS, Sprung CL. Diastolic dysfunction and mortality in severe sepsis and septic shock. EHJ. 2011; in press Epub 0.
51. Hallen J, Jensen JK, Fagerland MW, Jaffe AS, Atar D. Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction. Heart. 2010 Dec; 96(23):1892-7.
    View PubMed
52. Vasile VC, Chai HS, Khambatta S, Afessa B, Jaffe AS. Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease. Am J Med. 2010 Nov; 123(11):1049-58.
    View PubMed
53. Hallen J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D. Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus. Cardiovascular Diabetology. 2010 Sep 15; 9.
54. Thygesen K, Johannes M, Katus H, Plebani M, Verge P, Collinson P, Lindahl B, Giannitsis E, Hasin Y, Galvani M, Tubaro M, Alpert JS, Biasucci LM, Koenig W, Mueller CH, Huber K, Hamm C, Jaffe AS. The Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care Recommendations for the use of cardiac troponin measurement in acute cardiac care. EHJ. 2010 Sept; 31(18):2197-2204.
55. Baudhuin LM, Miller WL, Train L, Bryant S, Hartman KA, Phelps M, Larock M, Jaffe AS. Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure. Am J Cardiol. 2010 Aug 1; 106(3):402-8.
    View PubMed
56. Jaffe AS, Apple FS. In reply. Clin Chem. 2010 Jul; 56(7):1199-200. Epub 2010 May 20.
    View PubMed
57. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem. 2010 Jul; 56(7):1086-90. Epub 2010 May 14.
    View PubMed
58. Schulz O, Reinicke M, Berghoefer GH, Bensch R, Kraemer J, Schimke I, Jaffe AS. High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: an initial foray. Clin Chim Acta. 2010 Jun 3; 411(11-12):812-7. Epub 2010 Feb 24.
    View PubMed
59. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem. 2010 Jun; 56(6):941-3. Epub 2010 Apr 01.
    View PubMed
60. Arruda-Olson AM, Enriquez-Sarano M, Bursi F, Weston SA, Jaffe AS, Killian JM, Roger VL. Left ventricular function and C-reactive protein levels in acute myocardial infarction. Am J Cardiol. 2010 Apr 1; 105(7):917-21.
    View PubMed
61. Hess EP, Perry JJ, Calder LA, Thiruganasambandamoorthy V, Body R, Jaffe A, Wells GA, Stiell IG. Prospective validation of a modified thrombolysis in myocardial infarction risk score in emergency department patients with chest pain and possible acute coronary syndrome. Acad Emerg Med. 2010 Apr; 17(4):368-75.
    View PubMed
62. Kavsak PA, Worster A, You JJ, Oremus M, Elsharif A, Hill SA, Devereaux PJ, MacRae AR, Jaffe AS. Identification of myocardial injury in the emergency setting. Clin Biochem. 2010 Apr; 43(6):539-44. Epub 2009 Dec 21.
    View PubMed
63. Kavsak PA, Newman AM, Ko DT, Macrae AR, Jaffe AS. The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department. Clin Biochem. 2010 Mar; 43(4-5):505-7. Epub 2009 Nov 10.
    View PubMed
64. Jaffe AS, Apple FS. High-sensitivity cardiac troponin: hype, help, and reality. Clin Chem. 2010 Mar; 56(3):342-4. Epub 2009 Dec 29.
    View PubMed
65. Roger VL, Weston SA, Gerber Y, Killian JM, Dunlay SM, Jaffe AS, Bell MR, Kors J, Yawn BP, Jacobsen SJ. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation. 2010 Feb 23; 121(7):863-9. Epub 2010 Feb 08.
    View PubMed
66. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010 Feb; 56(2):254-61. Epub 2009 Dec 03.
    View PubMed
67. Cullen L, Than M, Brown AF, Richards M, Parsonage W, Flaws D, Hollander JE, Christenson RH, Kline JA, Goodacre S, Jaffe AS. Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia. Emerg Med Australas. 2010 Feb; 22(1):35-55. Epub 2010 Feb 04.
    View PubMed
68. Schulz O, Reinicke M, Berghoefer GH, Bensch R, Kraemer J, Schimke I, Jaffe AS. Erratum to High-sensitive cardiac troponin I (hs-cTnl) values in patients with stable cardiovascular disease: An initial foray [Clinica Chimica Acta., 411, (2010), 812-817]. Clin Chim Acta. 2010; 411(17-18):1395-6.
69. Hallen J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol. 2009 Dec 1; 104(11):1472-7. Epub 2009 Oct 14.
    View PubMed
70. Miller WL, Hartman KA, Hodge DO, Hartman S, Struck J, Morgenthaler NG, Bergmann A, Jaffe AS. Response of novel biomarkers to BNP infusion in patients with decompensated heart failure: a multimarker paradigm. J Cardiovasc Transl Res. 2009 Dec; 2(4):526-35. Epub 2009 Aug 14.
    View PubMed
71. Frye RL, Simari RD, Gersh BJ, Burnett JC, Brumm S, Myerle K, Jaffe AS, Holmes DR, Lerman A, Terzic A. Ethical issues in cardiovascular research involving humans. Circulation. 2009 Nov 24; 120(21):2113-21.
    View PubMed
72. Miller WL, Hartman KA, Burritt MF, Grill DE, Jaffe AS. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2009 Oct 27; 54(18):1715-21.
    View PubMed
73. Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem. 2009 Oct; 55(10):1809-15. Epub 2009 Aug 13.
    View PubMed
74. Saenger AK, Dalenberg DA, Bryant SC, Grebe SK, Jaffe AS. Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone. Clin Chem. 2009 Oct; 55(10):1869-75. Epub 2009 Aug 13.
    View PubMed
75. Neizel M, Futterer S, Steen H, Giannitsis E, Reinhardt L, Lossnitzer D, Lehrke S, Jaffe AS, Katus HA. Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. Clin Res Cardiol. 2009 Sep; 98(9):555-62. Epub 2009 Jul 07.
    View PubMed
76. Saenger AK, Lockwood C, Snozek CL, Milz TC, Karon BS, Scott MG, Jaffe AS. Catecholamine interference in enzymatic creatinine assays. Clin Chem. 2009 Sep; 55(9):1732-6. Epub 2009 Jul 09.
    View PubMed
77. Miller WL, Burnett JC Jr, Hartman KA, Hodge DO, Giuliani I, Minard F, Larue C, Jaffe AS. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide. Clin Chim Acta. 2009 Aug; 406(1-2):119-23. Epub 2009 Jun 11.
    View PubMed
78. Bang H, Mazumdar M, Newman G, Bomback AS, Ballantyne CM, Jaffe AS, August PA, Kshirsagar AV. Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience. Nephrol Dial Transplant. 2009 Aug; 24(8):2452-7. Epub 2009 Mar 26.
    View PubMed
79. Berridge BR, Pettit S, Walker DB, Jaffe AS, Schultze AE, Herman E, Reagan WJ, Lipshultz SE, Apple FS, York MJ. A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute. Am Heart J. 2009 Jul; 158(1):21-9.
    View PubMed
80. Kavsak PA, Wang X, Henderson M, Ko DT, MacRae AR, Jaffe AS. PAPP-A as a marker of increased long-term risk in patients with chest pain. Clin Biochem. 2009 Jul; 42(10-11):1012-8. Epub 2009 Mar 25.
    View PubMed
81. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperative myocardial infarction. Circulation. 2009 Jun 9; 119(22):2936-44.
    View PubMed
82. Hickson LT, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant. 2009 Jun; 9(6):1354-61. Epub 2009 May 13.
    View PubMed
83. Feng D, Syed IS, Martinez M, Oh JK, Jaffe AS, Grogan M, Edwards WD, Gertz MA, Klarich KW. Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009 May 12; 119(18):2490-7. Epub 2009 May 04.
    View PubMed
84. Gerber Y, Dunlay SM, Jaffe AS, McConnell JP, Weston SA, Killian JM, Roger VL. Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community. Atherosclerosis. 2009 Apr; 203(2):593-8. Epub 2008 Aug 07.
    View PubMed
85. Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de Jonge P, Davidson KW, Czajkowski SM, Jaffe AS. History of depression and survival following acute myocardial infarction. Psycho Med. 2009 Apr; 1:253-259.
86. Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de Jonge P, Davidson KW, Czajkowski SM, Jaffe AS. History of depression and survival after acute myocardial infarction. Psychosom Med. 2009 Apr; 71(3):253-9. Epub 2009 Feb 27.
    View PubMed
87. Vasile VC, Babuin L, Ting HH, Bell MR, Orme NM, Yuan BY, Perez JA, Alegria JR, Bellolio F, Haro LH, Jaffe AS. Aborted myocardial infarction: is it real in the troponin era? Am Heart J. 2009 Apr; 157(4):636-41. Epub 2009 Jan 31.
    View PubMed
88. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem. 2009 Mar; 55(3):573-7. Epub 2009 Jan 23.
    View PubMed
89. Bursi F, Barbieri A, Politi L, Di Girolamo A, Malagoli A, Grimaldi T, Rumolo A, Busani S, Girardis M, Jaffe AS, Modena MG. Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery. Eur J Vasc Endovasc Surg. 2009 Mar; 37(3):311-8. Epub 2008 Dec 25.
    View PubMed
90. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem. 2009 Jan; 55(1):85-92. Epub 2008 Nov 06.
    View PubMed
91. McConnell JP, Jaffe AS. The spin stops here: inhibition of lipoprotein-associated phospholipase A2-- a promising target but a negative initial trial? Clin Chem. 2009 Jan; 55(1):21-3. Epub 2008 Dec 01.
    View PubMed
92. Miller WL, Hartman KA, Grill DE, Burnett JC Jr, Jaffe AS. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. Clin Chem. 2009 Jan; 55(1):78-84. Epub 2008 Nov 21.
    View PubMed
93. Vasile VC, Babuin L, Rio Perez JA, Alegria JR, Song LM, Chai HS, Afessa B, Jaffe AS. Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding. Crit Care Med. 2009 Jan; 37(1):140-7.
    View PubMed
94. Saab PG, Bang H, Williams RB, Powell LH, Schneiderman N, Thoresen C, Burg M, Keefe F, for the ENRICHD Investigators. The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: The ENRICHD experience. J Psycho Res. 2009; 67:45-56.
95. Peleg A, Jaffe AS, Hasin Y. Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood. Clinica Chimica Acta. 2009; 409(1-2):85-89.
96. Vasile VC, Blauwet LA, Jaffe AS. Serial determination of troponin concentrations in the diagnosis of acute myocardial infarction. Heart and Metabolism. 2009; (43):27-9.
97. Vasile VC, Jaffe AS. The biological basis of troponin in heart disease: Possible uses for troponin fragmentology. Heart Metab. 2009(43):5-8.
98. Lett HS, Blumenthal JA, Babyak MA, Catellier DJ, Carney RM, Berkman LF, Burg MM, Mitchell P, Jaffe AS, Schneiderman N. Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction. Int J Behav Med. 2009; 16(3):248-58.
    View PubMed
99. Saenger AK, Jaffe AS. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation. 2008 Nov 18; 118(21):2200-6.
    View PubMed
100. Arruda-Olson AM, Pellikka PA, Bursi F, Jaffe AS, Santrach PJ, Kors JA, Killian JM, Weston SA, Roger VL. Left ventricular function and heart failure in myocardial infarction: impact of the new definition in the community. Am Heart J. 2008 Nov; 156(5):810-5. Epub 2008 Sep 09.
     View PubMed
101. Hickson LJ, Cosio FG, El-Zoghby ZM, Gloor JM, Kremers WK, Stegall MD, Griffin MD, Jaffe AS. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant. 2008 Nov; 8(11):2352-9. Epub 2008 Sep 10.
     View PubMed
102. Alpert JS, Thygesen K, White HD, Jaffe AS. Implications of the universal definition of myocardial infarction. Nat Clin Pract Cardiovasc Med. 2008 Nov; 5(11):678-9. Epub 2008 Sep 09.
     View PubMed
103. Thygesen K, Alpert JS, Jaffe AS, White HD. Diagnostic application of the universal definition of myocardial infarction in the intensive care unit. Curr Opin Crit Care. 2008 Oct; 14(5):543-8.
     View PubMed
104. Alpert JS, Thygesen K, Jaffe A, White HD. The universal definition of myocardial infarction: a consensus document: ischaemic heart disease. Heart. 2008 Oct; 94(10):1335-41.
     View PubMed
105. Trockel M, Burg M, Jaffe A, Barbour K, Taylor CB. Smoking behavior postmyocardial infarction among ENRICHD trial participants: Cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual. Psychosom Med. 2008 Oct; 70(8):875-82.
106. Jaffe AS. Key issues in the developing synergism between cardiovascular imaging and biomarkers. Clin Chem. 2008 Sep; 54(9):1432-42. Epub 2008 Aug 01.
     View PubMed
107. Carney RM, Steinmeyer B, Freedland KE, Blumenthal JA, Stein PK, Steinhoff WA, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Domitrovich PP, Burg MM, Hayano J, Jaffe AS. Nighttime heart rate and survival in depressed patients post acute myocardial infarction. Psychosom Med. 2008 Sep; 70(7):757-63. Epub 2008 Aug 25.
     View PubMed
108. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv. 2008 Aug; 1(1):10-9.
     View PubMed
109. Mockel M, Danne O, Muller R, Vollert JO, Muller C, Lueders C, Stork T, Frei U, Koenig W, Dietz R, Jaffe AS. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta. 2008 Jul 17; 393(2):103-9. Epub 2008 Mar 27.
     View PubMed
110. Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, Berkman LF, Watkins LL, Czajkowski SM, Burg MM, Jaffe AS. Depression and five year survival following acute myocardial infarction: a prospective study. J Affect Disord. 2008 Jul; 109(1-2):133-8. Epub 2008 Jan 11.
     View PubMed
111. Brune K, Katus HA, Moecks J, Spanuth E, Jaffe AS, Giannitsis E. N-terminal pro-B-type natriuretic peptide concentrations predict the risk of cardiovascular adverse events from antiinflammatory drugs: a pilot trial. Clin Chem. 2008 Jul; 54(7):1149-57. Epub 2008 May 01.
     View PubMed
112. Hess EP, Thiruganasambandamoorthy V, Wells GA, Erwin P, Jaffe AS, Hollander JE, Montori VM, Stiell IG. Diagnostic accuracy of clinical prediction rules to exclude acute coronary syndrome in the emergency department setting: a systematic review. CJEM. 2008 Jul; 10(4):373-82.
     View PubMed
113. Karon BS, Wockenfus A, Scott R, Hartman SJ, McConnell JP, Santrach PJ, Jaffe AS. Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. Clin Chem. 2008 Jun; 54(6):1060-5. Epub 2008 Apr 17.
     View PubMed
114. Miller WL, Kurien S, Warfield KT, Wood CM, Jaffe AS. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide. Int J Cardiol. 2008 May 23; 126(2):234-9. Epub 2007 May 07.
     View PubMed
115. Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? Clin Chem. 2008 Apr; 54(4):747-51.
     View PubMed
116. Kavsak PA, Ko DT, Newman AM, Lustig V, Palomaki GE, MacRae AR, Jaffe AS. Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification? Clin Biochem. 2008 Apr; 41(6):436-9. Epub 2007 Dec 27.
     View PubMed
117. Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol. 2008 Mar 10; 26(8):1231-8. Epub 2008 Feb 04.
     View PubMed
118. Dal-Bianco JP, Jaffe AS, Bell MR, Oh JK. Cardiac function and brain-type natriuretic peptide in first-time flash pulmonary edema. Mayo Clin Proc. 2008 Mar; 83(3):289-96.
     View PubMed
119. Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, Jaffe AS. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med. 2008 Mar; 36(3):759-65.
     View PubMed
120. Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH, NACB Committee, Ifcc C-Smcd. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. Clin Biochem. 2008 Mar; 41(4-5):222-6. Epub 2007 Nov 26.
     View PubMed
121. Lopez-Jimenez F, Wu CO, Tian X, O'Connor C, Rich MW, Burg MM, Sheps D, Raczynski J, Somers VK, Jaffe AS. Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience. Am Heart J. 2008 Mar; 155(3):478-84. Epub 2008 Jan 15.
     View PubMed
122. Moller JE, Bergeron S, Jaffe A, Pellikka PA. Influence of left ventricular filling pattern on exercise-induced changes of natriuretic peptides in patients with suspected coronary artery disease. Int J Cardiol. 2008 Feb 29; 124(2):204-10. Epub 2007 Apr 18.
     View PubMed
123. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J. 2008 Feb; 155(2):208-14. Epub 2007 Dec 19.
     View PubMed
124. Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol. 2008 Jan 22; 51(3):307-14.
     View PubMed
125. Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, Macrae AR, Jaffe AS. "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes. Clin Chim Acta. 2008 Jan; 387(1-2):133-8. Epub 2007 Oct 03.
     View PubMed
126. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytical and clinical utility of a next generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem. 2008.
127. Saenger AK, Jaffe AS. Requiem for a heavyweight. Circ. 2008; 118:2200-2206.
128. Jaffe AS. The clinical impact of the universal diagnosis of myocardial infarction. Clin Chem Lab Med. 2008; 46(11):1485-8.
     View PubMed
129. Hess EP, Wells GA, Jaffe A, Stiell IG. A study to derive a clinical decision rule for triage of emergency department patients with chest pain: design and methodology. BMC Emerg Med. 2008; 8:3. Epub 2008 Feb 06.
     View PubMed
130. Miller WL, Jaffe AS. Serial biomarker measurements in chronic heart failure. Cardiology Review. 2008; 25(3):53-8.
131. Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem. 2007 Dec; 53(12):2112-8. Epub 2007 Oct 11.
     View PubMed
132. Wu AHB, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, Newby LK, Ravkilde J, Tang WHW, Christenson RH, Cannon CP, Storrow AB. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem. 2007 Dec; 53(12):2086-96.
133. Miller WL, Targonski PV, Jaffe AS. B-type natriuretic peptides in heart failure: update on clinical applications and limitations. Biomark Med. 2007 Dec; 1(4):503-12.
     View PubMed
134. Vasile VC, Jaffe AS. New potential uses for cardiac troponins. Biomark Med. 2007 Dec; 1(4):491-501.
     View PubMed
135. Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, Syed II, Hughes DA, Lust JA, Jaffe AS, Gertz MA, Klarich KW. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007 Nov 20; 116(21):2420-6.
     View PubMed
136. Lee-Lewandrowski E, Januzzi JL, Green SM, Tannous B, Wu AH, Smith A, Wong A, Murakami MM, Kaczmarek J, Apple FS, Miller WL, Hartman K, Jaffe AS. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay. Clin Chim Acta. 2007 Nov-Dec; 386(1-2):20-4. Epub 2007 Jul 25.
     View PubMed
137. Schulz O, Paul-Walter C, Lehmann M, Abraham K, Berghoefer G, Schimke I, Jaffe AS. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. Am J Cardiol. 2007 Sep 1; 100(5):766-71.
138. Binder J, Ommen SR, Chen HH, Ackerman MJ, Tajik AJ, Jaffe AS. Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2007 Aug 15; 100(4):712-4. Epub 2007 Jun 19.
     View PubMed
139. Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, Lim CC, Bresnahan JF, Jaffe AS, Holmes DR, Bell MR. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation. 2007 Aug 14; 116(7):729-36. Epub 2007 Aug 01.
     View PubMed
140. Ghearing GR, Munger TM, Jaffe AS, Benarroch EE, Britton JW. Clinical cues for detecting ictal asystole. Clin Auton Res. 2007 Aug; 17(4):221-6. Epub 2007 Jul 16.
     View PubMed
141. Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH, Cannon CP, Francis G, Jesse RL, Morrow DA, Newby LK, Storrow AB, Tang WH, Pagani F, Tate J, Ordonez-Llanos J, Mair J, National Academy of Clinical Biochemistry, IFCC Committee for Standardization of National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. Circulation. 2007 Jul 31; 116(5):e95-8. Epub 2007 Jul 14.
     View PubMed
142. Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC Jr, Jaffe AS. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation. 2007 Jul 17; 116(3):249-57. Epub 2007 Jun 25.
     View PubMed
143. Saenger AK, Jaffe AS. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes. Med Clin North Am. 2007 Jul; 91(4):657-81; xi.
     View PubMed
144. Lett HS, Blumenthal JA, Babyak MA, Catellier DJ, Carney RM, Berkman LF, Burg MM, Mitchell P, Jaffe AS, Schneiderman N. Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol. 2007 Jul; 26(4):418-27.
     View PubMed
145. Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta. 2007 May 1; 380(1-2):213-6. Epub 2007 Jan 23.
     View PubMed
146. Jaffe AS. Cardiovascular biomarkers: the state of the art in 2006. Clin Chim Acta. 2007 May; 381(1):9-13. Epub 2007 Feb 22.
     View PubMed
147. Miller WL, Hartman KA, Burritt MF, Burnett JC Jr, Jaffe AS. Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clin Cardiol. 2007 May; 30(5):245-50.
     View PubMed
148. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, National Academy of Clinical Biochemistry, IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation. 2007 Apr 3; 115(13):e352-5. Epub 2007 Mar 23.
     View PubMed
149. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, Cannon CP, Francis G, Morrow DA, Ravkilde J, Storrow AB, Tang W, IFCC Comittee on Standardization of Markers of Cardiac Damege, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Panteghini M, Tate J, Nation National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem. 2007 Apr; 53(4):547-51. Epub 2007 Mar 23.
     View PubMed
150. Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin Biochem. 2007 Mar; 40(5-6):326-9.
     View PubMed
151. Friedewald VE, Arnold LW, Carney RM, Jaffe AS, Sheps DS, Roberts WC. The Editor's Roundtable: major depression in patients with coronary heart disease. Am J Cardiol. 2007 Feb 15; 99(4):519-29.
     View PubMed
152. Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Long-term health outcomes associated with detectable troponin I concentrations. Clin Chem. 2007 Feb; 53(2):220-7. Epub 2007 Jan 04.
     View PubMed
153. Carney RM, Howells WB, Blumenthal JA, Freedland KE, Stein PK, Berkman LF, Watkins LL, Czajkowski SM, Steinmeyer B, Hayano J, Domitrovich PP, Burg MM, Jaffe AS. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med. 2007 Jan; 69(1):4-9. Epub 2006 Dec 13.
     View PubMed
154. Hermsen D, Apple F, Garcia-Beltran L, Jaffe A, Karon B, Lewandrowski E, Muhlbacher A, Muller R, Ordonez J, Pagani F, Panteghini M, Plecko T, Jarausch J. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. Clin Lab. 2007; 53(1-2):1-9.
     View PubMed
155. Madsen LH, Christensen G, Lund T, Serebruany VL, Granger CB, Hoen I, Grieg Z, Alexander JH, Jaffe AS, Van Eyk JE, Atar D. Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ Res. 2006 Nov 10; 99(10):1141-7. Epub 2006 Oct 12.
     View PubMed
156. Kavsak PA, MacRae AR, Palomaki GE, Newman AM, Ko DT, Lustig V, Tu JV, Jaffe AS. Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naive emergency department patients. Clin Chem. 2006 Nov; 52(11):2028-35. Epub 2006 Sep 21.
     View PubMed
157. Gerber Y, McConnell JP, Jaffe AS, Weston SA, Killian JM, Roger VL. Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community. Arterioscler Thromb Vasc Biol. 2006 Nov; 26(11):2517-22. Epub 2006 Aug 10.
     View PubMed
158. Roger VL, Killian JM, Weston SA, Jaffe AS, Kors J, Santrach PJ, Tunstall-Pedoe H, Jacobsen SJ. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation. 2006 Aug 22; 114(8):790-7. Epub 2006 Aug 14.
     View PubMed
159. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol. 2006 Jul 4; 48(1):1-11. Epub 2006 Jun 12.
     View PubMed
160. Rana R, Vlahakis NE, Daniels CE, Jaffe AS, Klee GG, Hubmayr RD, Gajic O. B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med. 2006 Jul; 34(7):1941-6.
     View PubMed
161. Parvulescu-Codrea S, Britton JW, Bruce CJ, Cascino GD, Jaffe AS. Elevations of troponin in patients with epileptic seizures? What do they mean? Clin Cardiol. 2006 Jul; 29(7):325-6.
     View PubMed
162. Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J. 2006 Jul; 152(1):118-25.
     View PubMed
163. Jaffe AS, Krumholz HM, Catellier DJ, Freedland KE, Bittner V, Blumenthal JA, Calvin JE, Norman J, Sequeira R, O'Connor C, Rich MW, Sheps D, Wu C, Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Trial Investigators. Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Am Heart J. 2006 Jul; 152(1):126-35.
     View PubMed
164. Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, Murphy JG, Jaffe AS. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006 Jun 16; 110(2):153-9. Epub 2005 Jul 25.
     View PubMed
165. Lanman RB, Wolfert RL, Fleming JK, Jaffe AS, Roberts WL, Warnick GR, McConnell JP. Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults. Prev Cardiol. 2006 Summer; 9(3):138-43.
     View PubMed
166. Macrae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clin Chem. 2006 May; 52(5):812-8. Epub 2006 Mar 23.
     View PubMed
167. Miller WL, Garratt KN, Burritt MF, Lennon RJ, Reeder GS, Jaffe AS. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J. 2006 May; 27(9):1061-9. Epub 2006 Feb 15.
     View PubMed
168. Wright RS, Bybee K, Miller WL, Laudon DA, Murphy JG, Jaffe AS. Reduced risks of death and CHF are associated with statin therapy administered acutely within the first 24 h of AMI. Int J Cardiol. 2006 Apr 14; 108(3):314-9. Epub 2005 Jun 22.
     View PubMed
169. Williams BA, Wright RS, Murphy JG, Brilakis ES, Reeder GS, Jaffe AS. A new simplified immediate prognostic risk score for patients with acute myocardial infarction. Emerg Med J. 2006 Mar; 23(3):186-92.
     View PubMed
170. Maramattom BV, Manno EM, Fulgham JR, Jaffe AS, Wijdicks EF. Clinical importance of cardiac troponin release and cardiac abnormalities in patients with supratentorial cerebral hemorrhages. Mayo Clin Proc. 2006 Feb; 81(2):192-6.
     View PubMed
171. Rana R, Vlahakis NE, Daniels CE, Jaffe AS, Klee GG, Hubmayr RD, Gajic O. Uitlity of Early Measurement of Plasma B Type Natriuretic Peptide in the Assessment of Acute Lung Injury and Cardiogenic Pulmonary Edema. Critical Care Medicine. 2006; 33(12):A20.
172. Miller WL, Edwards BS, Kremers WK, Kushwaha SS, McGregor CGA, Daly RC, Jaffe AS. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. J Heart Lung Transplant. 2005 Dec; 24(12):2075-8.
173. Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ. 2005 Nov 8; 173(10):1191-202.
     View PubMed
174. Jaffe AS. Use of biomarkers in the emergency department and chest pain unit. Cardiol Clin. 2005 Nov; 23(4):453-65, vi.
     View PubMed
175. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AHB, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem. 2005 Nov; 51(11):2198-200.
     View PubMed
176. Bursi F, Babuin L, Barbieri A, Politi L, Zennaro M, Grimaldi T, Rumolo A, Gargiulo M, Stella A, Modena MG, Jaffe AS. Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation. Eur Heart J. 2005 Nov; 26(22):2448-56.
     View PubMed
177. Gheorghiade M, Stough WG, Adams KF, Jaffe AS, Hasselblad V, O'Connor CM. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF). Am J Cardiol 2005 Sep 19; 96(6A Suppl S):18G-25G.
     View PubMed
178. Miller WL, Burnett JC Jr, Hartman KA, Henle MP, Burritt MF, Jaffe AS. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol. 2005 Sep 15; 96(6):837-41.
     View PubMed
179. Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Domitrovich PP, Jaffe AS. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med. 2005 Jul 11; 165(13):1486-91.
     View PubMed
180. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, Burg MM, Kaufmann PG, Shuster J, Mellman T, Blumenthal JA, Krishnan R, Jaffe AS. Effects of antideressant medication of morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005 Jul; 62(7):792-8.
     View PubMed
181. Wright RS, Bybee K, Miller WL, Laudon DA, Murphy JG, Jaffe AS. Reduced risks of death and CHF are associated with statin therapy administered acutely within the first 24 h of AMI. Int J Cardiol. 2005 Jun 21.
182. Gibler WB, Cannon CP, Blomkalns AL, Char DM, Drew BJ, Hollander JE, Jaffe AS, Jesse RL, Newby LK, Ohman EM, Peterson ED, Pollack CV. Practical Implementation of the guidelines for unstable angina/non-st-segment elevation myocardial infarction in the emergency department. Ann Emergency Med. 2005,May 24; 111:2699 - 270.
183. Apple FS, Wu AHB, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem. 2005 May; 51(5):810-24.
     View PubMed
184. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AHB, Tate J, Pagani F, Christenson RH, Jaffe AS. Quality specifications for B-type natriuretic peptide assays. Clin Chem. 2005 Mar; 51(3):486-93.
     View PubMed
185. Miller WL, Hartman KA, Burritt MF, Borgeson DD, Burnett JC Jr, Jaffe AS. Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure. Clin Chem. 2005 Mar; 51(3):569-77. Epub 2004 Dec 22.
     View PubMed
186. Gibler WB, Cannon CP, Blomkalns AL, Char DM, Drew BJ, Hollander JE, Jaffe AS, Jesse RL, Newby LK, Ohman EM, Peterson ED, Pollack CV. Practical implementation of the guidelines for unstable angina/non-st-segment elevation myocardial infarction in the emergency department. Circulation. 2005; 111:2699-2710.
     View PubMed
187. Gheorghiade M, Gattis Stough W, Pharm D, Adams Jr KF, Jaffe AS, Hasselbland V, O'Connor CM. The PRESERVD-HF Study. AJC Supplement. 2005(18G - 25G).
188. Miller WL, Burnett Jr JC, Hartman KA, Henle MP, Burritt MF, Jaffe AS. Lower Rather Than Higer Levels of B-Type Natriuretic Peptides (NT-Pro-BNP) Predict short-Term Mortality in End-Stage Heart Failure Patients Treated With Nesiritide. Am J Cardio. 2005; 96:837-841.
189. Williams BA, Wright RS, Murphy JG, Miller WL, Reeder GS, Jaffe AS. A new simplified immediate prognostic risk score for patients with acute myocardial infarction. Emergency Medical Journal. 2005.
190. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS. The quantification of infarct size. J Am Coll Cardiol. 2004 Oct 19; 44(8):1533-42.
     View PubMed
191. Gulati M, Patel S, Jaffe AS, Joseph AJ, Calvin JE. Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in the registry of acute coronary syndromes. Am J Cardiol. 2004 Oct 1; 94(7):873-8.
     View PubMed
192. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, Witzig TE, Lust JA, Rajkumar SV, Fonseca R, Zeldenrust SR, McGregor CG, Jaffe AS. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004 Sep 15; 22(18):3751-7.
     View PubMed
193. Perez EA, Suman VJ, Davidson NE, Kaufman PA, Martino S, Dakhil SR, Ingle JN, Rodeheffer RJ, Gersh BJ, Jaffe AS. Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J Clin Oncol. 2004 Sep 15; 22(18):3700-4.
     View PubMed
194. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, McConnell JP, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Hogan WJ, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust S Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2004 Sep 15; 104(6):1881-7.
     View PubMed
195. Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, Wright RS, Rihal CS. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004 Aug 1; 94(3):343-6.
     View PubMed
196. Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith RC, Burg MM, Cornell C, Saab PG, Kaufmann PG, Czajkowski SM, Jaffe AS. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med. 2004 Jul-Aug; 66(4):466-74.
     View PubMed
197. La Vecchia L, Ottani F, Favero L, Spadaro GL, Rubboli A, Boanno C, Mezzena G, Fontanelli A, Jaffe AS. Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism. Heart (British Cardiac Society) 2004 Jun; 90(6):633-7.
     View PubMed
198. Gami AS, Svatikova A, Wolk R, Olson EJ, Duenwald CJ, Jaffe AS, Somers VK. Cardiac troponin T in obstructive sleep apnea. Chest. 2004 Jun; 125(6):2097-100.
     View PubMed
199. Miller WL, Garratt KN, Burritt MF, Reeder GS, Jaffe AS. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. Chest. 2004 Jan; 125(1):275-80.
     View PubMed
200. Carney RM, Blumenthal JA, Catellier D, Freedland KE, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Jaffe AS. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 2003 Dec 1; 92(11):1277-81.
     View PubMed
201. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DG, Levy D, Manolio T, Mendis S, Mensah G, Pajak A, Prineas RJ, Reddy KS, Roger VL, Rosamond WD, Shahar E, Sharrett AR, Sorlie P, Tunstall-Pedoe H. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003 Nov 18; 108(20):2543-9.
     View PubMed
202. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. Effects of treating depression and low-perceived social support on clinical events after myocardial infarction - The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA: Journal of the American Medical Association. 2003 Jun 18; 289(23):3106-16.
     View PubMed
203. Woodruff BK, Britton JW, Tigaran S, Cascino GD, Burritt M, McConnell JP, Ravkilde J, Molgaard H, Andreasen F, Dam M, Jaffe AS. Cardiac troponin levels following monitored epileptic seizures. Neurology. 2003 May 27; 60(10):1690-2.
     View PubMed
204. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, McConnell JP, Burritt MF, Jaffe AS. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet. 2003 May 24; 361(9371):1787-9.
     View PubMed
205. Carney RM, Freedland KE, Stein PK, Watkins LL, Catellier D, Jaffe AS, Yeragani VK. Effects of depression on QT interval variability after myocardial infarction. Psychosom Med. 2003 Mar-Apr; 65(2):177-80.
     View PubMed
206. Tigaran S, Molgaard H, McClelland R, Dam M, Jaffe AS. Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients. Neurology. 2003 Feb 11; 60(3):492-5.
     View PubMed
207. Gheorghiade M, Gattis WA, Adams KF, Jaffe AS, O'Connor CM. Rationale and design of the Pilot Randomized Study of Nesiritide versus Dobutamine in Heart Failure (PRESERVD-HF). Am Heart J. 2003 Feb; 145(2 Suppl S):S55-7.
     View PubMed
208. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2003 Jan-Feb; 65(1):119-28.
     View PubMed
209. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J. 2002 Dec; 144(6):981-6.
     View PubMed
210. Aviles RJ, Wright RS, Aviles JM, McDonald F, Ballman K, Harker-Murray A, Scott C, Lauer MS, Kopecky SL, Jaffe AS. Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin I levels. Am J Cardiol. 2002 Oct 15; 90(8):875-8.
     View PubMed
211. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002 Oct 1; 137(7):563-70.
     View PubMed
212. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity - A review of potential mechanisms. J Psychosom Res. 2002 Oct; 53(4):897-902.
     View PubMed
213. Wright RS, Williams BA, Cramner H, Gallahue F, Willmore T, Lewis L, Ladenson JH, Jaffe AS. Elevations of cardiac troponin I are associated with increased short-term mortality in noncardiac critically ill emergency department patients. Am J Cardiol. 2002 Sep 15; 90(6):634-6.
     View PubMed
214. Carlson RJ, Navone A, McConnell JP, Burritt M, Castle MC, Grill D, Jaffe AS. Effect of myocardial ischemia on cardiac troponin I and T. Am J Cardiol. 2002 Jan 15; 89(2):224-6.
     View PubMed
215. Cantwell RV, Aviles RJ, Bjornsson J, Wright RS, Freeman WK, Oh JK, Hoyer JD, Markovic S, Jaffe AS. Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris. Clin Cardiol. 2002 Jan; 25(1):33-7.
     View PubMed
216. McConnell JP, Branum EL, Ballman KV, Lagerstedt SA, Katzmann JA, Jaffe AS. Gender differences in C-reactive protein concentrations - Confirmation with two sensitive methods. Clinical Chemistry & Laboratory Medicine. 2002; 40(1):56-9.
     View PubMed
217. Jaffe AS, World Health Organization, European Society of Cardiology, American College of Cardiology. New standard for the diagnosis of acute myocardial infarction. Cardiol Rev. 2001 Nov-Dec; 9(6):318-22.
     View PubMed
218. Miller WL, Wright RS, McGregor CG, Dispenzieri A, McConnell JP, Burritt MF, Jaffe AS. Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation. Am J Cardiol. 2001 Oct 1; 88(7):813-5.
     View PubMed
219. ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. Psychosom Med. 2001 Sep-Oct; 63(5):747-55.
     View PubMed
220. Antman EM, Corbalan R, Huber K, Jaffe AS. Issues in early risk stratification for UA/NSTEMI. European Heart Journal Supplement. 2001 Aug; 3(J):J6-J14.
221. Carney RM, Freedland KE, Jaffe AS. Depression as a risk factor for coronary heart disease mortality. Arch Gen Psychiatry. 2001 Mar; 58(3):229-30.
     View PubMed
222. Jaffe AS. Diagnosis of Acute Myocardial Infarction: The Use of Troponin Markers. Israeli Heart Journal. 2001.
223. Jaffe AS. Elevations in cardiac troponin measurements: false false-positives: the real truth. Cardiovasc Toxicol. 2001; 1(2):87-92.
     View PubMed
224. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. The ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease (ENRICHD): Baseline Characteristics. Amer J Card. 2001; 88:316-22.
225. Jacobs I, Callanan V, Nichol G, Valenzuela T, Mason P, Jaffe AS, Landau W, Vetter N. The Chain of Survival. Annals of Emergency Medicine/Journal of the American College of Emergency Physicians S5 2001; 37(4).
226. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, Jaffe AS. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J. 2000 Dec; 140(6):917-27.
     View PubMed
227. Dixit S, Castle M, Velu RP, Swisher L, Hodge C, Jaffe AS. Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac troponin I. Arch Intern Med. 2000 Nov 13; 160(20):3153-8.
     View PubMed
228. Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, Jaffe AS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med. 2000 Sep-Oct; 62(5):639-47.
     View PubMed
229. Alpert JS, Antman E, Apple F, Armstrong PW, Bassand JP, de Luna G, Breithardt G, Chaitman BR, Clemmensen P, Falk E, Fishbein MC, Galvani M, Garson A, Grines C, Hamm C, Jaffe AS, Katus H, Kjekshus J, Klein W, Klootwijk P, Lenfant C, Levy D, Levy RI, Luepke Myocardial infarction redefined - A consensus document of the Joint European Society of cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Journal of the American College of Cardiology. 2000 Sep; 36(3):959-69.
     View PubMed
230. Hutter AM, Amsterdam EA, Jaffe AS. Task force 2: acute coronary syndromes: Section 2B - chest discomfort evaluation in the hospital. J Am Coll Cardiol. 2000 Mar 15; 35(4):853-862.
     View PubMed
231. Stein PK, Carney RM, Freedland KE, Skala JA, Jaffe AS, Kleiger RE, Rottman JN. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. Journal of Psychosomatic Research. 2000; 48:493-500.
232. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. Enhancing recovery in coronary heart disease (ENRICHD) patients study: Study design and methods. American Heart Journal. 2000; 139:1-9.
     View PubMed
233. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2000; 66:639-47.
234. Carney RM, Freedland KE, Veith RC, Cryer PE, Skala JA, Lynch T, Jaffe AS. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry. 1999 Feb 15; 45(4):458-63.
     View PubMed
235. Carney RM, Freedland EK, Veith RC, Jaffe AS. Can treating depression reduce mortality after an acute myocardail infarction? Psychosomatic Medicine. 1999; 61:666-75.
     View PubMed
236. Ottani F, Galvani M, Ferrini D, Ladenson JH, Puggioni R, Destro A, Baccos D, Bosi S, Ronchi A, Rusticali, Jaffe AS. Direct comparison of early elevations of cardiac troponin T and I in patients with unstable angina. AHJ. 1999; 137:284-91.
     View PubMed
237. Jaffe AS. The use of troponin measurements in patients with unstable angina. International Journal of Cardiology 68 Suppl. 1999; 1:S49-53.
238. Jaffe AS. 2001--a biomarker odyssey. Clin Chim Acta. 1999 Jun 30;284(2):197-211.
239. Jaffe AS, Landau WM, Wetzel RD. Resuscitation 2000: the need for improved databases in regard to neurological outcomes. Resuscitation. 1998; 37:65-6.
     View PubMed
240. Carney RM, Freedland KE, Eisen SA, Rich MW, Skala JA, Jaffe AS. Adherence to a prophyllactic medication regimen in patients with symptomatic vs asymptomatic ischemic heart disease Behavioral Medicine. 1998; 24:35-9.
     View PubMed
241. Landt M, Lawson GM, Helgeson JM, Davila-Roman VG, Ladenson JH, Jaffe AS, Hickner RC. Prolonged exercise decreases serum leptin concentrations. Metabolism: Clinical & Experimental. 1997 Oct; 46(10):1109-12.
     View PubMed
242. Selis SP, Hom M, Sequeira JM, Tritel M, Gindea A, Ladenson JH, Jaffe AS, Esposito R. Time course of lysophosphatydylcholine relase from ischemic human myocardium parallels the time course of early ischemic ventricular arrhythmia Coron Art Disease. 1997; 8:19-27.
243. Davila-Roman V, Guest TH, Tuteur PG, Rowe WJ, Ladenson JH, Jaffe AS. Transient right but not left ventricular dysfunction after strenuous exercise at high altitude JACC. 1997; 30:468-73.
     View PubMed
244. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis: Experimental and clinical correlates Circulation. 1997; 95:163-8.
     View PubMed
245. Hirsch R, Landt Y, Porter S, Canter CE, Jaffe AS, Ladenson JH, Grant JW, Landt M. Cardiac troponin I in Pediatrics: Normal values and potential use in the assessment of cardiac injury J Peds. 1997; 130:827-72.
246. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, Rusticali F, Jaffe AS. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 1997; 95:2053-9.
     View PubMed
247. Allan JJ, Feld RD, Russell AA, Ladenson JH, Rogers MAM, Kerber RI, Jaffe AS. Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion JACC. 1997; 30:1052-6.
     View PubMed
248. Jaffe AS. More rapid diagnosis of myocardial infarction: Is it worthwhile? American Family Physician. 1997; 55:2591-2594.
     View PubMed
249. Jaffe AS. Rationale for the use of conjunctive anticoagulation during thrombolysis. In Review in Depth Sobel BE Coron Art Dis. 1996; 7:491-6.
250. Fiedotin NA, Freedland KE, Carney RM, Skala JA, Rich MW, Jaffe AS. Depression, medical utilization in patients in chronic heart failure. Annuals of Behavioral Medicine. 1996:S134.
251. Adams JE, Davila-Roman VG, Bessey PQ, Blake DP, Ladenson JH, Jaffe AS. Improved detection of cardiac contusion with cardiac troponin I Am Heart J. 1996; 131:308-12.
     View PubMed
252. Jaffe AS, Landt Y, Parvin CA, Abendschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for the diagnosing acute myocardial infarction Clin Chem. 1996; 42:1770-6.
     View PubMed
253. Carney RM, Freedland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms. Ann Behav Med. 1995 Spring; 17(2):142-9.
     View PubMed
254. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease AJC. 1995; 76:562-4.
255. Guest TM, Ramanathan AV, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill medical patients: A surprisingly frequent complication JAMA 49 1995 1945-19; 273:1945-9.
256. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease Health Psychology. 1995; 14:88-90.
     View PubMed
257. Grant JW, Canter CE, Spray TL, Landt Y, Saffitz JE, Ladenson JH, Jaffe AS. Elevated donor cardiac troponin I: A marker of acute graft failure in infant heart recipients Circulation. 1994; 90:2618-21.
     View PubMed
258. Adams JE III, Schechtman K, Landt V, Landenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I Clin Chem 7 1994; 40:1291-5.
259. Jaffe AS, Eisenberg PR, Abendschein DR. Conjoint use of MM and MB creatine kinase isoforms for detection of coronary recanalization Am Heart J. 1994; 127:1461-6.
     View PubMed
260. Adams JE, Sicard G, Allan BT, Bridwell KH, Lenke LG, Davila-Roman VG, Bodor GS, Ladenson JH, Jaffe AS. Diagnosis of perioperative myocardial infarction with masurement of cardiac troponin I N Engl J Med. 1994; 330:670-4.
     View PubMed
261. Lenke LG, Bridwel KH, Jaffe AS. Increase inc reatine kinase MB isoenzyme levels and spinal surgery J Spinal Disorders. 1994; 7:70-6.
262. Adams JE 3rd, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993 Jul; 88(1):101-6.
     View PubMed
263. Goldstein JA, Tweddell JS, Barzilai B, Yagi Y, Jaffe AS, Cox JL. Hemodynamic effects of atrial ineraction Cor ARt Dis. 1993; 4:545-53.
264. Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease Am J Med. 1993; 95:23-8.
     View PubMed
265. Eisenberg MS, Aghababian RV, Bossaert L, Jaffe AS, Ornato JP, Weaver WD. Thrombolytic therapy. Ann Emerg Med. 1993; 22:417-27.
     View PubMed
266. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: Is MB creatine kinase the choice for the 1990's? Circulation. 1993; 88:750-63.
     View PubMed
267. Jaffe AS, Landau WM. Clinical neuromythology XI death after death: The presumption of informed consent for CPR, ethical paradox, clinical conundrum. Neurology. 1993; 43:2173-8.
     View PubMed
268. Jaffe AS. The use of antiarrhythmias in advanced cardiac life support. Ann Emerg Med. 1993; 22:307-16.
     View PubMed
269. Jaffe AS, Deedwania PC, Higginson LA, Boden WE, Mehta JL, Ferlinz J, Walsh RA, Sullivan JM, Vokonas PS, Cabin H, et al. Diagnostic and therapeutic implications: exploration through case discussions. Am J Cardiol. 1992 Nov 16; 70(16):45F-48F.
     View PubMed
270. Jaffe AS. Effects of diabetes on the heart. (Overview) Cor Artery Dis. 1992; 3:1-3.
271. Jaffe AS. The use of intravenous diltiazem in patients with acute coronary artery disease. Am J Cardiol. 1992; 69:25B-9B.
     View PubMed
272. Carney RM, Freedland KE, Smith LJ, Rich MW, Jaffe AS. Relation of depression and mortality after myocardial infarction in women. Circulation. 1992; 84:1876-77.
273. Jaffe AS, Emergency Cardiac Care Committee. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care JAMA. 1992; 268:2171-81.
     View PubMed
274. Adams JE, Siegel BA, Goldstein JA, Jaffe AS. Elevations of CK-MB following pulmonary embolism: A manifestation of occult right ventricular infarction Chest. 1992; 101:1203-6.
     View PubMed
275. Goldstein JA, Kenzora JL, Jaffe AS. Coronary angiography with a novel mobile x-ray image intensifier Coronary ARtery Dis. 1992; 3:1065-71.
276. Carney RM, Freedland KE, Clark KA, Skala JA, Smith L, Delamater A, Jaffe AS. Psychosocial adjustment of patients arriving early at the emergency department after acute myocardial infarction Am J Cardiol. 1992; 69:160-2.
     View PubMed
277. Prager NA, Suzuki T, Jaffe AS, Sobel BE, Abendschein DR. The nature and time course of generation of isoforms of MB creatine kinase in vivo JACC. 1992; 20:414-9.
     View PubMed
278. Eisenberg PR, Sobel BE, Jaffe AS. Activation of prothrombin accompanying thrombolysis with rt-PA JACC. 1992; 19:1065-9.
     View PubMed
279. Goldstein JA, Tweddell JS, Barzilai B, Yagi Y, Jaffe AS, Cox JL. Importance of LV function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia JACC. 1992; 19:704-11.
     View PubMed
280. Freedland KE, CArney RM, Lustman PJ, Rich MW, Jaffe AS. Major depression in coronary artery disease, patients with versus without a prior history of depression Psychosomatic Med. 1992; 54:416-21.
281. Goldstein JA, Tweddell JS, Barzilai B, Yagi Y, Jaffe AS, Cox JL. Right atrial ischemia exacerbates hemodynamic compromise associated with experimental right ventricular dysfunction JACC. 1991; 18:564-72.
282. Eisenberg PR, Kenzora J, Sobel BE, Ludbrook PA, Jaffe AS. Relation between ST segment shifts during ischemia and thrombin activity in patients with unstable angina JACC. 1991; 18:893-903.
283. Abendschein DA, Ellis AK, Eisenberg PR, Klocke FJ, Sobel BE, Jaffe AS. Prompt detection of coronary recanalization by analysis of rates of change of concentrations of macromolecular markers in plasma Cor ARt Dis. 1991; 2:201-12.
284. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Boyle PJ, Falqui L, Marchetti P, Ricordi C, Gingerich RL, Jaffe AS, Cryer PE, Hanto DW, Anderson CB, Flye MW. Results of our first nine intraportal islet allografts in type I insulin dependent diabetic patients Transplantation. 1991; 51:76-85.
     View PubMed
285. Carney RM, Freedland KE, Jaffe AS. Altered circadian variation of acute myocardial infarction in patients with depression Coronary Artery Disease. 1991; 2:61-5.
286. Hartwell TD, Parker CB, Poole WK, Davis VG, Muller JE, Braunwald E, Robertson T, Rutherford J, Sobel BE, Strauss W, Thomas L, Roberts R, Jaffe AS, Willerson JT. Reproducibility of centralized laboratory interpretations of measures of myocardial infarct size, ventricular function, and ventricular electrical instability scintigraphy Coronary ARtery Disease. 1991; 2:997-84.
287. Atkins JM, Mentzer RM, Field JM, Ornato JP, Francis CK, Passamani ER, Gibson RS, Prediman KS, Goldberg SJ, Smith HC, et al. Recommended guidelines for in-hospital cardiac monitoring of adults for detection of arrhythmia. Am Coll Cardiol. 1991; 18(6):1431-3.
288. Cummins RO, Ornato JP, Thies WH, Pepe PE, Billi JE, Seidel J, Jaffe AS, Flint LS, Goldstein S, Abramson NS, Brown C, Chandra NC, Gonzalez ER, Newell L, Stults KR, Membrino GE. Improving survival from sudden cardiac arrest: The "Chain of Survival" Concept. Circulation. 1991; 83:1832-47.
     View PubMed
289. Carney RM, Freedland KE, Sapira JD, Jaffe AS. Panic disorder and depression in patients with chest pain not due to coronary artery disease. Am J Cardiol (letter) 1990; 15:1048.
290. Cummins RO, Thies W, Paraskos J, Kerber RE, Billi JE, Seidel J, Jaffe AS, Flint L, Ornato JP, Abramson NS, Brown C, Chandra NC, Gonzales ER, Newell L, Stults KR, Membrino GE, Pepe PE. Encouraging early defibrillation: The American Heart Association and automated external defibrillation. Ann Emerg Med. 1990; 19:1245-8.
     View PubMed
291. Vered I, Vered Z, Perez JE, Jaffe AS, Whyte MP. Normal left ventricular function in children with x-linked hypophosphatemic rickets. A Doppler echocardiography study J Bone Min Res. 1990; 5:469-74.
292. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Falqui L, Marchetti P, Gingerish RL, Jaffe AS, Cryer PE, Anderson CB, Flye MW. Insulin independence after Islet transplantation into Type I diabetic patient Diabetes. 1990; 39:515-18.
     View PubMed
293. Carney RM, Freeland KE, Ludbrook PA, Saunders RD, Jaffe AS. Major depression, panic disorder, and mitral valve prolapse in patients who complainof chest pain Am J Med. 1990; 89:757-60.
     View PubMed
294. Goldstein JA, Barzilai B, Rosamond TL, Eisenberg PR, Jaffe AS. Determinants of hemodynamic compromise with severe right ventricular infarction Circulation. 1990; 82:469-368.
295. Eisenberg PR, Jaffe AS, Stump DC, Collen DJ, Bovill EG. Validity of enzyme-linked immunoabsorbent assays of cross-linked fibrin degradation products as a measure of clot lysis Circulation. 1990; 82:1159-68.
     View PubMed
296. Barzilai B, Davis VG, Stone PH, Jaffe AS, MILIS study group. Prognostic significance fo mitral regurgitation in acute myocardial infarction AM J Cardiol. 1990; 65:1169-75.
     View PubMed
297. Eisenberg PR, Lucore C, Kaufman L, Sobel BE, Jaffe AS, Rich S. Elevations of levels of fibrinopeptid A indicative of pulmonary vascular thrombosis in patient with primary pulmonary hypertension Circulation. 1990; 82:841-7.
     View PubMed
298. Carney RM, Freedland KE, Jaffe AS. Insomnia and Depression Prior to Myocardial Infarction Psychosomatic Medicine. 1990; 52:603-9.
     View PubMed
299. Winters KJ, Eisenberg PR, JAffe AS, Santoro SA. Dependence of plasmin-mediated degradation of platelet adhesive receptors on temperature and CA++ concentration Blood. 1990; 76:1546-57.
     View PubMed
300. Cohen ML, Barzilai B, Gutierrez F, Jaffe AS, Eisenberg P. Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activator. Am Heart J. 1990; 120:978-9.
     View PubMed
301. Jaffe AS. Automated defibrillation: A problem, a challenge and an opportunity - The role of Internists and cardiologists in the prehospital care of their patients Cont Intern Med 8-1 1990.
302. Jaffe AS, TIMI study group. Comparison of invaasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction - Results of the thrombolysis in myocardial infarction (TIMI) phase II trial N Engl J Med. 1989; 320:618-27.
     View PubMed
303. Vered I, Vered Z, Perez JE, Jaffe AS, Whyte MP. Normal left ventricular performance documented by Doppler echocardiography in patients with longstanding hypocalcemia AM J Med. 1989; 86:413-6.
     View PubMed
304. Eisenberg PR, Shaw D, Schaab C, Jaffe AS. Concordance of creatine kinase-MB activity and mass Clin Chem. 1989; 35:440-3.
     View PubMed
305. Scharp D, Lacy P, Ricordi C, Boyle P, Santiago J, Cryer P, Gingerick R, Jaffe AS, Anderson C, Flye W. Human islet transplantation in patient with type-1 diabetes Transplant Proc. 1989; 21:2744-5.
     View PubMed
306. Carney RM, Freedland K, Rich MW, Jaffe AS. Stimulus induced analgesia and silent myocardial ischemia. J Appl Cardiol. 1989; 4:271-4.
307. Devries S, Jaffe AS, Geltman EM, Sobel BE, Abendschein D. Enzymatic estimation of the extent of irreversible myocardial injury early after reperfusion. Am Heart J. 1989; 117:31-6.
     View PubMed
308. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss WH, Willerson JT, Sobel BE, Robertson T, Passamani E, Braunwald E, Jaffe AS, MILIS Study Group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis J Am Coll Cardiol. 1989; 14:49-57.
     View PubMed
309. Jaffe AS. Cardiovascular effects of diabetes. Curr Opin in Cardiol. 1989; 4:711-20.